Oncology Precision Medicine Market GRÖSSEN- UND MARKTANTEILSANALYSE - WACHSTUMSTRENDS UND PROGNOSEN (2024 - 2031)

Oncology Precision Medicine Market is segmented By Type of Cancer (Bladder Cancer, Blood / Hematologic Cancer, Breast Cancer, Cervical Cancer, Gastrointestinal Cancer, Head and Neck Squamous Cell Cancer, Lung Cancer, Skin Cancer, Others), By Route of Administration (Oral, Intravenous, Others), By Type of Molecule (Small Molecules, Biologics), By Drug Class (Kinase Inhibitors, Enzyme Inhibitors, Immune Checkpoint Inhibitors, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa). The report offers the value (in USD Billion) for the above-mentioned segments.

Competitive overview of Oncology Precision Medicine Market

Zu den wichtigsten Akteuren des Global Oncology Precision Medicine Market gehören Amgen, BioNTech, Gilead Sciences, Merck & Co., Illumina, Foundation Medicine, Guardant Health, Caris Life Sciences, Exact Sciences, Myriad Genetics, Thermo Fisher Scientific, Invitae, Genomic Health, Syapse und Tempus.

Oncology Precision Medicine Market Leaders

  • AstraZeneca
  • Novartis
  • Pfeifen
  • Bristol-Myers Squibb
  • Rochen
*Disclaimer: Major players are listed in no particular order.

Oncology Precision Medicine Market - Competitive Rivalry, 2023

Market Concentration Graph

Oncology Precision Medicine Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights